Related Experiment Video
Updated: Aug 5, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
Lymphoplasmapheresis for Refractory Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report
Rui Tian1, Zhenglian Luo2, Zhen Hong1
1Department of Neurology and Institute of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lymphoplasmapheresis (LPE) may be a valuable treatment for refractory anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. This case study shows LPE improved a patient
Area of Science:
- Neuroimmunology
- Neurology
- Immunotherapy
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune neurological disorder.
- While typically responsive to immunotherapy, some patients exhibit refractory disease.
- Salvage therapies are needed for treatment-resistant NMDAR encephalitis.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction